Cyclacel Pharmaceuticals, Inc. (CYCC) Financials
Stock symbol CYCC is outdated, potentially delisted? Maybe it is available on other exchange?
CYCC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 4401 | 770 |
| March 31, 2025 | 3.7 million | 672000 |
| Dec. 31, 2024 | 4.1 million | 6.3 million |
| Sept. 30, 2024 | 5.4 million | 6.4 million |
CYCC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | -1056 | 7 |
| March 31, 2025 | -3247 | 1666 |
| Dec. 31, 2024 | -1.4 million | 93000 |
| Sept. 30, 2024 | -3.1 million | 107000 |
CYCC Net Income
No data available :(
CYCC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 4275 | - | 10000 |
| March 31, 2025 | 3.5 million | 9000 | 9000 |
| Dec. 31, 2024 | 3.1 million | - | - |
| Sept. 30, 2024 | 3.0 million | - | - |
CYCC Shares Outstanding
CYCC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | - | 68 | 1249 | - |
| March 31, 2025 | - | 822000 | 4.2 million | - |
| Dec. 31, 2024 | - | 879000 | 948000 | - |
| Sept. 30, 2024 | - | 950000 | 1.2 million | 1.2 million |
CYCC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | - | - |
| March 31, 2025 | -35000 | 4000 |
| Dec. 31, 2024 | -35000 | 4000 |
| Sept. 30, 2024 | 10000 | 1000 |
CYCC
Price: $6.36
52 week price:
Dividend Yield: 2.01%
Forward Dividend Yield: 2.36%
Payout Ratio Range:
Dividend Per Share: 0.15 USD
Earnings Per Share: 7123.50 USD
P/E Ratio: 0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123100
Ebitda: -2.1 millionMarket Capitalization: 12.4 million
Years Paying Dividends: 1